Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

SOLVEZINE DIN 02234061

Status: Marketed
Holder: NORBROOK LABORATORIES LTD.
Molecule: FLUNIXIN (FLUNIXIN MEGLUMINE)

Health Canada record

Active ingredient(s)FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG
Dosage formSolution
RouteIntramuscular; Intravenous
SchedulePRESCRIPTION
ClassVeterinary
ATC
Original market date18-Nov-1997
Current status date20-Mar-2026
SourceHealth Canada DPD

Establishment licence of the holder

Norbrook Laboratories Limited — licence , not currently licensed, last inspection rating C (2025-02-25).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing FLUNIXIN (FLUNIXIN MEGLUMINE)

DINProductCompanyFormStrengthStatus
00465305BANAMINEINTERVET CANADA CORPSolutionFLUNIXIN (FLUNIXIN MEGLUMINE) 50 MGMarketed
02457180BANAMINEINTERVET CANADA CORPSolutionFLUNIXIN (FLUNIXIN MEGLUMINE) 50 MGMarketed
02240510FLUNAZINEBIMEDA-MTC ANIMAL HEALTH INCSolutionFLUNIXIN (FLUNIXIN MEGLUMINE) 50 MGMarketed
02563584FLUTREXINMODERN VETERINARY THERAPEUTICS LLCSolutionFLUNIXIN (FLUNIXIN MEGLUMINE) 50 MGMarketed
02550474SOLNIXONBIMEDA-MTC ANIMAL HEALTH INCSolutionFLUNIXIN (FLUNIXIN MEGLUMINE) 50 MGMarketed
00465291BANAMINE GRANULESSCHERING-PLOUGH CANADA INCGranulesFLUNIXIN (FLUNIXIN MEGLUMINE) 25 MGCancelled Post Market
02231381CITATION INJECTIONBAYER INC., ANIMAL HEALTHLiquidFLUNIXIN (FLUNIXIN MEGLUMINE) 50 MGCancelled Post Market
02230652CRONYXIN INJECTIONCROSS VETPHARM GROUP LTDSolutionFLUNIXIN (FLUNIXIN MEGLUMINE) 50 MGCancelled Post Market
02239149INFLUX-50 (FLUNIXIN MEGLUMINE INJECTION) STERILE INJECTABLE SOLUTIONVETOQUINOL N A INCSolutionFLUNIXIN (FLUNIXIN MEGLUMINE) 50 MGCancelled Post Market
02248807SUPPRESSORNORBROOK LABORATORIES LTD.SolutionFLUNIXIN (FLUNIXIN MEGLUMINE) 50 MGCancelled Post Market
02478951VETONIXINNORBROOK LABORATORIES LTD.SolutionFLUNIXIN (FLUNIXIN MEGLUMINE) 50 MGDormant

Notices of Compliance

NOCDateSubmissionReason
357372025-07-25Supplement to an Abbreviated New Drug Submission (SANDS)Administrative - Change in brand name
112082010-04-01Supplement to an Abbreviated New Drug Submission (SANDS)New indication
94292008-03-19Supplement to an Abbreviated New Drug Submission (SANDS)FOR THE CONTROL OF PYREXIA IN BOVINE RESPIRATORY DISEASE, AND THE CONTROL OF PYREXIA AND INFLAMMATION ASSOCIATED WITH ENDOTOXEMIA, IN BEEF CATTLE AND NON-LACTATING DAIRY CATTLE
66841997-10-14New Drug Submission (NDS)
Request a quote for SOLVEZINE

How to read a Canadian DIN record